Barrot H. Lambdin

Barrot H. Lambdin, an Epidemiologist and Implementation Scientist, is currently a Fellow within the Center for Behavioral Health and Implementation Science in RTI International’s Health Practice Area. He is also an assistant adjunct professor within the Department of Epidemiology and Biostatistics at the University of California, San Francisco, and an affiliate assistant professor within the Department of Global Health at the University of Washington.

Over the last 20 years, Dr. Lambdin has led implementation science initiatives throughout the world that have identified determinants and tested strategies to advance the implementation of evidence-based interventions in community-based organizations and healthcare settings. These initiatives have included community-based naloxone distribution, syringe services programs and supervised consumption services in the United States, opioid treatment in Tanzania, as well as HIV prevention and treatment in Tanzania, Zambia, Mozambique, Zimbabwe, and the United States. Most recently, he has served as the principal investigator on several NIH-funded and foundation funded initiatives to optimize our nation’s efforts to reduce opioid overdose fatalities and the impacts of various state-level drug policy initiatives.

Currently, Dr. Lambdin leverages his expertise to evaluate the impact of state-level policy initiatives on implementation of evidence-based interventions, including Oregon’s ballot measure to decriminalize non-commercial drug possession. This study aims to conduct a comprehensive outcome evaluation to understand the impact of Oregon’s Ballot Measure 110, which decriminalized non-commercial drug possession for a period of time and increased funding for substance use disorder treatment and harm reduction services. He also leads an effort to annually conduct the National Survey of Syringe Services Programs, which is used by leading scientists across the country to study the implementation of syringe services programs and the services they deliver. 

Additionally, Dr. Lambdin leads the study, Improving Equitable Distribution of Naloxone from Syringe Services Programs. The major goal of this study assesses the effectiveness of the Systems Analysis and Improvement Approach to increase the equitable distribution of naloxone from syringe service programs throughout California.